The recent clearance reconfirms the freedom to utilize the entire volume of EQUASHIELD's Syringe Unit, leading to enhanced cost savings and safety with handling of hazardous drugs. PORT WASHINGTON, ...

New PP&P State of Pharmacy Compounding report shows EQUASHIELD ® now accounts for 44% of CSTDs in use for hazardous drug preparation PORT WASHINGTON, N.Y., May 8, 2026 /PRNewswire/ -- In a healthcare ...

PORT WASHINGTON, N.Y., April 22, 2026 /PRNewswire/ -- In recognition of Earth Day 2026, EQUASHIELD ®, a global leader in hazardous drug handling, today announced its transition to electronic ...

Equashield is the first to introduce CSTDs to Romania, helping protect healthcare workers in light of increased demand for chemotherapy drugs PORT WASHINGTON, New ...

EQUASHIELD , a pioneer in closed system transfer devices (CSTDs) and automated pharmacy compounding solutions, is thrilled to announce its remarkable achievement of being named by the Pharmacy ...

CODAN to Distribute Advanced Equashield II Product in Birthplace of Closed System Transfer Device Concept The entrance of EQUASHIELD ® into the Swedish market is striking, as the first closed system ...

Equashield Remains the Provider of Choice and Most Considered Closed System Transfer Device for Pharmacists and Oncology Nurses in Prevention of Hazardous Drug Exposure A growing number of facilities ...

(MENAFN- PR Newswire) PORT WASHINGTON, N.Y., Oct. 3, 2023 /PRNewswire/ -- EQUASHIELD®, a leading provider of Closed System Transfer Devices (CSTDs) for hazardous drugs, is thrilled to announce that ...